‘A transformative game-changer’: Firm specializing in cell and gene therapy to team with Pitt at Hazelwood Green

The University of Pittsburgh has landed the first tenant for its proposed BioForge biomanufacturing facility at Hazelwood Green — a Cambridge, Mass.-based firm that specializes in the development of cell and gene therapies.

Pitt is partnering with ElevateBio under a 30-year agreement that is designed to bring the research and manufacturing of cutting edge, life giving treatments to the former coke plant on the banks of the Monongahela River.

As part of the deal, ElevateBio will build within BioForge an 80,000-square-foot facility known as BaseCamp that will be involved in the research, development, and manufacturing of cell and gene therapeutics and technologies, including gene editing.

The Hazelwood BaseCamp will be ElevateBio’s first outside of Waltham, Mass.

Click here to read the full article from the Pittsburgh Post-Gazette.